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Cannabinoids attenuate hippocampal gamma oscillations
by suppressing excitatory synaptic input onto CA3
pyramidal neurons and fast spiking basket cells
No´ emi Holderith, Be´ ata N´ e m e t h ,O r s o l y aI .P a p p ,J u d i tM .V e r e s ,G e r g o ´´ A. Nagy and Norbert H´ ajos
Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary
Non-technicalsummary Administrationofcannabinoidscanimpairseveralcognitivefunctions,
including memory by altering synchronous activities in cortical networks. We show that the
gamma frequency (40Hz) oscillations in hippocampal slices, that are prominent oscillations in
electroencephalogram during awake states in vivo, are reduced by cannabinoids. This effect can
be explained by the suppression of the excitatory synaptic transmission onto fast spiking basket
cells, GABAergic cells that are key players in oscillogenesis. The reduced excitatory drive onto
these interneurons leads to a reduction in neuronal ﬁring frequency and precision, and thus to
smaller ﬁeld potentials. Our data further our understanding of the synaptic mechanisms of how
cannabinoids alter neuronal operation.
Abstract CB1 cannabinoidreceptor(CB1R)activationbyexogenousligandscanimpairmemory
processes, which critically depend on synchronous neuronal activities that are temporarily
structured by oscillations. In this study, we aimed to reveal the mechanisms underlying
the cannabinoid-induced decrease in gamma oscillations. We ﬁrst veriﬁed that cannabinoids
(CP55,940 and WIN55,212-2) readily suppressed carbachol-induced gamma oscillations in the
CA3 region of hippocampal slices via activation of CB1Rs. The cannabinoid-induced decrease
in the peak power of oscillations was accompanied by reduced and less precise ﬁring activity
in CA3 pyramidal cells and fast spiking basket cells. By examining the cannabinoid sensitivity
of synaptic inputs we found that the amplitude of evoked excitatory postsynaptic currents was
signiﬁcantlysuppresseduponCB1RactivationinbothCA3pyramidalcellsandfastspikingbasket
cells. In contrast, evoked inhibitory postsynaptic currents in CA3 pyramidal cells were unaltered.
Furthermore, we observed that a CB1R agonist-induced decrease in the oscillation power at
the beginning of the drug application was accompanied primarily by the reduced discharge of
fast spiking basket cells, while pyramidal cell ﬁring was unaltered. This result implies that the
dampening of cholinergically induced gamma oscillations in the hippocampus by cannabinoids
canbeexplainedbyareducedexcitatoryinputpredominantlyontofastspikingbasketcells,which
leadstoareductioninneuronalﬁringfrequencyandprecision,andthustosmallerﬁeldpotentials.
In addition, we uncovered that the spontaneously occurring sharp wave-ripple activities in
hippocampal slices could also be suppressed by CB1R activation suggesting that cannabinoids
profoundly reduce the intrinsically generated oscillatory activities at distinct frequencies in CA3
networks by reducing synaptic neurotransmission.
(Resubmitted 14 July 2011; accepted after revision 22 August 2011; ﬁrst published online 22 August 2011)
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CP55,940, (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol; FSBC, fast
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Introduction
The emergence of gamma frequency (30–80Hz)
oscillations in cortical neuronal networks is often
associated with higher cognitive functions, including
attention, sensory encoding and memory storage or
retrieval (Singer, 1993; Tiitinen et al. 1993; Sederberg
et al. 2003; Montgomery & Buzsaki, 2007). Recent
evidence suggests that these oscillations can support
neuronal communication and synaptic plasticity (Fell
& Axmacher, 2011). To understand the cellular and
networkmechanismsunderlyingthegenerationofgamma
oscillations in cortical structures, a number of in vitro
models of gamma oscillations have been introduced
(Whittington et al. 1995; Fisahn et al. 1998; Hajos et al.
2000).
In one of these models, cholinergic receptor activation
induces gamma oscillations in the CA3 region of
hippocampal slices, a brain region that is able to
intrinsically generate synchronous network activities
both in behaving animals and in vitro (Fisahn et al.
1998; Csicsvari et al. 2003). Importantly, this model
has been shown to capture several features of gamma
oscillations recorded in vivo (Hajos & Paulsen, 2009).
Recent studies uncovered that the cholinergically induced
gamma oscillations in the hippocampus are generated
by a recurrent synaptic feedback loop comprised of CA3
pyramidal cells and fast spiking basket cells (Mann et al.
2005; Gulyas et al. 2010). During such oscillatory activity,
the discharge of principal cells is governed by perisomatic
inhibition, whereas the ﬁring of GABAergic interneurons
is driven by excitatory input (Oren et al. 2006). The
frequency and the magnitude of these oscillations are
primarily determined by the decaying phase and the
amplitudeofperisomaticinhibitorycurrents,respectively
(Fisahn et al. 1998; Oren et al. 2010).
Previous in vitro and in vivo studies (Hajos et al.
2000; Robbe et al. 2006; Robbe & Buzsaki, 2009)
indicatedthatcannabinoids,whichaffectseveralcognitive
processes including short term memory (Lichtman et al.
1995; Hampson & Deadwyler, 1998), can effectively
suppressoscillatoryactivitiesin,amongothers,thegamma
frequency range. This effect of cannabinoids is probably
accomplishedviaactivationofCB1 cannabinoidreceptors
(CB1Rs) (Robbe et al. 2006). The G-protein-coupled
CB1Rs in cortical networks are predominantly, if not
exclusively, located at axon terminals (Katona et al.
1999, 2006; Kawamura et al. 2006), thereby efﬁciently
controlling neurotransmitter release (Kano et al. 2009).
In the hippocampus, these receptors are present at axon
terminals of pyramidal cells and one type of GABAergic
interneuron that express cholecystokinin (CCK) (Katona
et al. 1999; Hajos et al. 2000). Thus, cannabinoids can
regulate both excitatory transmission and a subset of
inhibitory synapses in hippocampal circuits (Katona &
Freund, 2008; Kano et al. 2009).
As in vitro studies revealed, application of cholinergic
receptor agonists can block GABA release from the axon
terminals of CCK-containing basket cells, an effect that
was shown to be accomplished via CB1Ra c t i v a t i o n
(Fukudome et al. 2004; Neu et al. 2007; Szabo et al.
2010). We recently veriﬁed that these interneurons do
not contribute to oscillations induced by the cholinergic
receptor agonist carbachol (Gulyas et al. 2010). Hence,
we hypothesize that cannabinoid receptor agonists reduce
the extent of excitatory synaptic transmission, resulting
in the suppression of gamma oscillations. Whereas the
transmitter release from recurrent collaterals in CA3
pyramidal cells has been shown to be regulated by CB1R
activation (Hofmann et al. 2008), excitatory input onto
hippocampal interneurons seems to be insensitive to
cannabinoids (Hoffman et al. 2003). Therefore, we tested
the hypothesis of whether the suppression of recurrent
excitation between CA3 pyramidal cells by cannabinoid
agonists can account for the cellular mechanisms under-
lying the dampening of cholinergically induced gamma
oscillationsinthehippocampus.Inaddition,weexamined
the cannabinoid sensitivity of sharp wave-ripple activities
(SWRs) occurring spontaneously in the CA3 region of
hippocampal slices. In intact animals, these synchronous
events in local electroencephalogram are present pre-
dominantly during consummatory activity, immobility
and slow wave sleep (Buzs´ aki, 1989; Buzs´ aki et al. 1992).
Methods
Slice preparation
All experiments were performed in accordance with the
Hungarian Act of Animal Care and Experimentation
(1998,XXVIII,section243/1998),andwiththeguidelines
of the institutional ethical code. The experiments comply
withthepoliciesandregulationsasrequiredbyTheJournal
of Physiology (Drummond, 2009). A total of 59 mice were
used in this study. CD1 mice of both sexes (Charles River,
Budapest, Hungary) or CB1R knockout mice and their
wild type littermates (Zimmer et al. 1999) (postnatal
day 14 (P14)–P26) were deeply anaesthetized with iso-
ﬂurane.Afterdecapitation,thebrainwasquicklyremoved
and placed into ice-cold cutting solution containing (in
mM): sucrose, 252; KCl, 2.5; NaHCO3, 26; CaCl2, 0.5;
MgCl2,5 ;N a H 2PO4, 1.25; glucose, 10; and bubbled with
95% O2 and 5% CO2. Horizontal slices 350–400μm
thick for studying oscillations and 150–200μm thick for
investigatingpostsynapticcurrents,respectively,werepre-
pared using a Leica (Nussloch, Germany) VT1000S or
VT1200S vibratome. Slices containing the hippocampal
formation were trimmed from other brain regions and
kept in an interface-type holding chamber at room
temperature for at least 60min before recording in
standard aCSF containing (in mM): NaCl, 126; KCl,
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2.5; NaHCO3, 26; CaCl2, 2; MgCl2,2 ;N a H 2PO4, 1.25;
glucose, 10; and bubbled with 95% O2 and 5% CO2
(pH 7.2–7.4).
Electrophysiological recordings
To examine the cannabinoid effects on oscillations,
experiments were performed in the CA3 region of
the hippocampus using a dual-superfusion recording
chamber in aCSF at 30–32◦Ca taﬂ o wr a t eo f
3.5–5mlmin−1 (Hajos & Mody, 2009). Oscillatory
activities emerged either spontaneously in the case of
SWRs or were induced by bath application of 10μM
carbachol,whichwaspresentthroughouttheexperiments.
The power and the frequency of oscillations stabilized
within 10–15min after carbachol application (Hajos &
Mody, 2009). Local ﬁeld potentials and the spiking
activity of cells were simultaneously recorded with two
patch pipettes (pulled from borosilicate glass capillaries,
resistance 3–6M ) ﬁlled with aCSF. One pipette was
placedwithinthepyramidalcelllayeroftheCA3bregionat
a depth of 100–200μm to monitor local ﬁeld oscillations.
Theotherpipettewasusedundervisualguidancetodetect
action potentials extracellularly from neurons. Pyramidal
cells were selected based on the shape of their cell bodies,
whereas interneurons with somata at the border of strata
pyramidale and oriens were targeted if they ﬁred almost
ineveryoscillationcycle.Aftertheextracellularrecording,
the recorded cell was labelled with a different pipette
usingthewhole-cellpatch-clamptechnique.Forlabelling,
the intracellular solution contained (in mM): potassium
gluconate, 110; NaCl, 4; creatine phosphate, 10; Hepes,
10; ATP, 2; GTP, 0.4; and 0.3–0.5% biocytin (pH 7.3;
290–300mosmoll−1). Only interneurons that could be
identiﬁedasfastspikingbasketcellsbasedonbothelectro-
physiological and anatomical criteria were included in
this study (n=7). All such interneurons showed high
spiking rates and phase-coupling strengths, and often
ﬁred doublets of action potentials, characteristic features
that are only observed in fast spiking basket cells during
carbachol-induced oscillations (Gulyas et al. 2010). The
axon arbor of each interneuron was restricted to stratum
pyramidale, and using double ﬂuorescent staining we
determinedthattheirlabelledboutonsavoidedaxoninitial
segments of pyramidal cells, indicating that they were not
axo-axonic cells (see below).
For stimulation experiments, a theta glass electrode
was placed in the stratum radiatum at a distance of
200–400μm from the recorded cells. To detect evoked
excitatory postsynaptic currents (EPSCs), the pipette
solution was the same as above, but 600–800μM
picrotoxin was added to intracellularly block GABAA
receptor-mediated currents. For evoked inhibitory post-
synaptic currents (IPSCs), 2–3mM kynurenic acid was
added to the bath solution, while the pipette solution
contained(inmM):CsCl,80;caesiumgluconate,60;NaCl,
3;creatinephosphate,10;MgCl2,1;Hepes,10;ATP,2;and
QX314,5(pH7.3,290–300mosmoll−1).Theﬂowratewas
∼2mlmin −1. Recordings were performed at a holding
potential of −65mV. Access resistance (between 5–
15M , compensated 70–80%) was frequently monitored
andcellswereexcludedfromanalysisiftheseriesresistance
changed more than 25%. All recorded neurons were post
hoc anatomically identiﬁed. Only CA3 pyramidal cells
(n=29) and anatomically identiﬁed basket cells with a
fastspikingphenotype(n=18)wereincludedinthestudy.
The fast spiking character of interneurons was tested and
distinguished from a regular spiking discharge pattern by
injection of depolarizing current steps immediately after
obtainingthewhole-cellrecordingconﬁguration,whereas
the morphological identiﬁcation was performed post hoc
(Gulyas et al. 2010).
All data were recorded with a Multiclamp 700B
ampliﬁer (Axon Instruments, Foster City, CA, USA).
Signals were low-pass ﬁltered at 2kHz. Data acquisition
was done with a PCI-6024E board (National Instruments,
Austin, TX, USA) using EVAN 1.3 (courtesy of Professor
I. Mody, Departments of Neurology and Physiology,
UCLA, CA, USA) and analysed ofﬂine using Origin 8.0
(OriginLab Corp. Northampton, MA, USA) and Matlab
6.0 (MathWorks Natick, MA, USA) softwares.
Data analysis
Power spectra density analysis was performed on
120–180s epochs. Time windows of 1s with 50% over-
lap were multiplied by a Hanning window before a fast
Fourier transform was performed. Peak power and peak
frequency at that power value were used for comparison.
A custom-written ﬁring phase detection algorithm was
used as described in detail previously (Gulyas et al. 2010).
Spikes recorded in a loose-patch mode for 120–180s
were detected by manually setting the threshold on the
unﬁltered trace. The negative peak of the trough of
the oscillation was considered as phase zero for ﬁeld
potentials band-pass ﬁltered with an RC ﬁlter between
5 and 500Hz. The phase of individual spikes was
speciﬁed by calculating the position of the unit spikes
in relation to two subsequent negative phase time points.
The amplitude and the instantaneous frequency of the
oscillation varied, and often the detection algorithm
skipped one or more oscillation cycles. Therefore, our
spike phase detection algorithm checked for the actual
detected cycle length and assigned a phase to a spike
only if the actual cycle length did not differ from the
mean of the average cycle length by more than a chosen
fraction of 0.3 standard deviations of the cycle length.
Phase values of individual cells were analysed by circular
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statistical methods using Oriana 2.0 software (Kovach
Computing Services, Anglesey, UK). Signiﬁcant deviation
from uniform (random) phase distribution along the
circle indicated directionality. This was tested with Rao’s
spacingtestandRayleigh’suniformitytest.Tocharacterize
a non-uniform distribution, two parameters of its mean
vector (calculated from individual observations) were
used, the mean angle and the length of the mean vector,
i.e. the phase-coupling strength.
Toevaluatethechangesinthepeakamplitudeofevoked
postsynaptic currents upon CB1R activation, control
amplitudes in a 2–3min time window were compared to
thosemeasuredafter20mindrugapplicationforthesame
period of time. Only those experiments were included
that had stable amplitudes at least for 10min before drug
application. After each experiment, the Teﬂon tubing of
the setup was washed with ethanol for 10min and with
aCSF for 15min.
The peak amplitudes of SWRs and their incidence
before and after the drug application were analysed by
EVAN software.
Data are presented as mean±SEM unless otherwise
indicated. Statistical comparisons were performed in
OriginPro8.0usingtheStudent’spairedt testfornormally
distributedlineardataandtheWilcoxon’ssignedranktest
for linear data that were not normally distributed.
Anatomical identiﬁcation of cells
After recording, slices were ﬁxed in 4% paraformaldehyde
in 0.1 M phosphate buffer (PB; pH 7.4) for at least 60min,
followed by washout with PB several times, cryoprotected
in 20% sucrose and then repeatedly freeze-thawed (for
detailsseeHajosetal.2004).Biocytinwasvisualizedusing
an avidin–biotinylated horseradish peroxidase complex
reaction (ABC; Vector Laboratories, Burlingame, CA,
USA) with nickel-intensiﬁed 3,3-diaminobenzidine as
chromogen.
Identiﬁcation of fast spiking basket cells using double
immunoﬂuorescent labelling
The details of this procedure have been published pre-
viously (Gulyas et al. 2010). Brieﬂy, after recording,
the slices were ﬁxed as above, washed, cryoprotected,
embeddedin1%agarandre-sectionedat60μmthickness.
The sections were treated with 0.2mgml−1 pepsin (Cat.
No. S3002; Dako, Glostrup, Denmark) in 0.2 M HCl at
37◦Cfor5minandwerewashedin0.1 MPB.Sectionswere
blocked in normal goat serum (NGS, 10%) made up in
Tris-buffered saline (TBS, pH 7.4) followed by incubation
in mouse anti-AnkyrinG (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) diluted 1:100 in TBS containing
2% NGS and 0.3% Triton X-100. Following several
washes in TBS, Cy3-conjugated goat anti-mouse (1:500,
Jackson Laboratories, Bar Harbor, ME, USA) was used to
visualize the immunoreactions, and Alexa488-conjugated
strepavidin (1:500; Invitrogen, Carlsbad, CA, USA) to
visualize the biocytin. Sections were then mounted on
slides in Vectashield (Vector Laboratories, Burlingame,
CA, USA). Images were taken using an AxioImager.Z1
(Carl Zeiss GmbH, Vienna, Austria).
Drugs
WIN55,212-2,CP55,940andNBQXwerepurchasedfrom
Tocris (Tocris Bioscience Ltd, Bristol, UK). WIN55,212-2
was dissolved in 0.1 N HCl giving a 20mM stock solution
stored at 4◦C prior to dilution to working concentration.
CP55,940 and NBQX were dissolved in DMSO and in
water, respectively (both at a concentration of 100mM),
andstoredat–20 ◦C.SR141716A(dissolvedas10mMstock
inDMSOandstoredat4◦C)wasprovidedbytheNational
Institute on Drug Abuse (NIDA) drug supply service. In
control solutions, the vehicle was diluted in the same
concentration as in the solutions containing drugs. All
other drugs were obtained from Sigma-Aldrich (St Louis,
MO, USA).
Results
Effect of CB1R activation on cholinergically induced
oscillations in the hippocampus
Bath application of the acetylcholine receptor agonist
carbachol at a concentration of 10μM readily induced
synchronous network activities in mouse hippocampal
slices at 30–32◦C, which could be detected as oscillations
in local ﬁeld potentials recorded in the pyramidal cell
layer of the hippocampal CA3 region (Fig.1A). The
average peak frequency (30.1±1.5Hz, n=13) and mean
peakpower(87.9±20.3μV2,n=13)oftheseoscillations
calculated from the power spectral density function were
comparable to results reported previously in studies
using slices prepared from the rat hippocampus (Fisahn
et al. 1998; Hajos et al. 2004; Oren et al. 2006). First,
we asked whether cholinergically induced oscillations
could be controlled by CB1R activation, similarly to
that observed for kainate-induced network oscillations
(Hajos et al. 2000). Indeed, addition of CB1R agonists
CP55,940 or WIN55,212-2 to the bath solution at a
concentration of 1 μM signiﬁcantly decreased the power
of the oscillations (Fig.1A and B,l e f tp a n e l s ) .A f t e r
20min of bath application of these agonists, the peak
power of oscillatory activities was signiﬁcantly reduced
to 62.1±6.3% of control and 54.7±15.2% of control
forCP55,940andWIN55,212-2,respectively(Fig.1C and
D, left panels, Table1) without a substantial change in
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the frequency (105.9±2.8% of control for CP55,940
and 103.3±5.1% of control for WIN55,212-2; Fig.1C
and D, right panels, Table1). The reduction in the peak
power caused by CP55,940 (control: 98.1±16.2μV2;
in CP55,940: 61.8±11.8μV2; n=3; P =0.024) could
be fully reversed by subsequent co-application of the
CB1R antagonist SR141716A at a concentration of 1μM
(in CP55,940 + SR141716A: 90.1±12.9μV2; n=3;
P =0.019). Moreover, the pre-treatment of slices with
SR141716A for 1h prevented the CP55,940-induced
drop in oscillation power (in SR141716A: 67.4±9.3μV2;
in SR141716A + CP55,940: 64.9±8.8μV2; P =0.23;
n=3). Importantly, SR141716A alone did not change the
parameters of the oscillation (control: 69.8±10.4μV2
and 34.3±2.2Hz; in SR141716A: 67.4±9.3μV2 and
31.8±2.4Hz;P =0.15andP =0.19,respectively,n=3),
suggesting the lack of tonic CB1R activation in our slice
preparations that could interfere with oscillogenesis. To
further conﬁrm that cannabinoids acted exclusively via
CB1Rs, we tested the speciﬁcity of these agonists using
CB1Rk n o c k o u tm i c e( F i g .1 A and B right panels). The
properties of carbachol-induced oscillations in slices pre-
pared from CB1R knockout mice were not different
from those observed in their wild type littermates
(peak frequency: 31.1±1.1Hz, n=10, P =0.64; peak
gamma power: 103.6±21.5μV2, n=10, P =0.6). Bath
application of CB1R agonists for 20min did not
change the peak power (101.4±6.4% of control for
CP55,940 and 102.4±12.3% for WIN55,212-2; Fig.1C
and D, left panel, Table1) or frequency (96.3±2.8%
of control for CP55,940 and 95.4±2.3% of control for
WIN55,212-2; Fig.1C and D, right panels, Table1) of the
oscillations. These results indicated that both synthetic
cannabinoids could signiﬁcantly reduce the peak power
of cholinergically induced oscillations in the CA3 subﬁeld
via activation of CB1Rs.
CB1R activation suppresses the ﬁring rate of CA3
pyramidal cells and fast spiking interneurons during
gamma oscillations
Whatmightbethemechanismunderlyingthereductionof
theoscillationpowerasaconsequenceofthecannabinoid
agonist treatment? In the in vitro model of gamma
oscillationsinducedbycarbachol,therhythmicinhibitory
currents originating from the periodic discharge of
parvalbumin-containing fast spiking basket cells (FSBCs)
generatethemajorityofﬁeldpotentialoscillations(Mann
et al. 2005; Atallah & Scanziani, 2009; Sohal et al.
2009; Gulyas et al. 2010; Oren et al. 2010). Hence,
we hypothesized that perisomatic inhibition should be
suppressed by cannabinoids in order to reduce the power
of gamma oscillations. Since FSBCs do not express
CB1Rs at their axon terminals (Katona et al. 1999;
Figure 1. CB1R activation reduces the power of the
cholinergically induced gamma oscillations in the CA3 region
of the hippocampus
A, example traces of extracellular ﬁeld recordings of cholinergically
induced oscillations (10 μM carbachol) in the pyramidal cell layer of
CA3 in a wild type animal (WT, left traces) and in a CB1R knockout
mouse (CB1RK O( C B 1R−/−), right traces) before (upper black traces)
and after bath application of the cannabinoid receptor agonist
CP55,940 (1 μM) (lower grey traces). B, power spectra calculated
from the power spectral density function (PSD) of the traces in A
showing peaks between 25–30 Hz (black), with harmonics both in
t h eW Ta n di nt h eC B 1RK Oa n i m a l s .C B 1R agonist application
reduced the peak power and is accompanied by a modest shift in
the peak frequency (grey). No change was detected in the CB1RK O
animals (right). C, comparison of the peak power (left) and peak
frequency (right) change in wild type (ﬁlled circles) and CB1RK O
(open circles) animals. D, summary graphs showing the reduction in
peak power (left) due to the bath application of either CP55,940 or
WIN55,212-2 (1 μM, asterisks indicates P < 0.05) without substantial
changes in the peak frequency (right). Scale bars, 0.1 mV and 50 ms.
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Table 1. Basic properties of cholinergically induced network oscillations in the CA3 region
of the hippocampus under control conditions and 20 min after drug application
Genotype Property Control CP55,940 P value Number
WT Peak frequency (Hz) 28.9 ± 1.53 0 .6 ± 1.7 0.097 7
Peak power (μV2) 136 ± 18.58 0 .4 ± 10.4 0.0098 7
CB1R KO Peak frequency (Hz) 28.7 ± 1.12 7 .8 ± 1.00 . 3 2 5
Peak power (μV2) 140.8 ± 34.3 153.3 ± 85.90 . 1 1 5
Genotype Property Control WIN55,212-2 P value Number
WT Peak frequency (Hz) 30.1 ± 2.23 0 .7 ± 1.20 . 6 9 5
Peak power (μV2)7 0 .3 ± 17.54 5 .2 ± 13.7 0.027 5
CB1R KO Peak frequency (Hz) 33.4 ± 1.13 1 .8 ± 0.70 . 1 2 5
Peak power (μV2)6 6 .5 ± 14.86 7 .5 ± 12.90 . 9 1 5
Data were compared using the Student’s paired t test: signiﬁcant differences are indicated
in italics. Data are presented as mean ± SEM.
Hajos et al. 2000), cannabinoids cannot directly control
their synaptic output (Hajos et al. 2000; Ohno-Shosaku
et al. 2002). Thus, the reduction of synchronized GABA
release during gamma oscillations can only be achieved
either by a decrease in the ﬁring frequency of FSBCs
or by the de-synchronization of their spiking activity
without a change in the mean frequency (Andersson
et al. 2010; Gulyas et al. 2010). To reveal which scenario
m i g h tb er e s p o n s i b l ef o rt h eC B 1R-mediated reduction
in oscillations, we simultaneously recorded local ﬁeld
potentials and the spiking activity of individual neurons,
which were post hoc anatomically identiﬁed. In this set
of experiments, we ﬁrst monitored the discharge of CA3
pyramidal cells using a loose-patch mode in parallel with
the ﬁeld oscillation. As Fig.2 shows, bath application of
CP55,940 (1μM) resulted in a signiﬁcant decrease in the
ﬁring rate of pyramidal cells to 55.2±9.2% of control
(Fig.2A,l e f tp a n e l ,a n dB, Table2) along with a change
in the power of the oscillation (50.2±5.3% of control,
control: 146.5±16.7μV2, in CP55,940: 72.2±8.1μV2,
n=6, P =0.002). In addition to the spiking activity, the
phase-coupling strength of spiking was also found to
be reduced after drug treatment without any change in
the mean phase (Table2). Under identical conditions, we
next investigated the ﬁring behaviour of FSBCs, which
dischargedinalmosteveryoscillationcycleandoftenﬁred
doublets of action potentials (Fig.2A, right panel, and
C). In addition to the substantial dampening of the ﬁeld
oscillationuponCB 1Ractivation(53.3±7.1%ofcontrol,
control: 117.3±25.6μV2, CP55,940: 58.4±13.2μV2,
n=7, P =0.028), the spiking activity of FSBCs was also
suppressedto62.2±7.1%ofcontrol(Fig.2,Table2).The
reduced ﬁring rate was complemented by a decrease in
the phase-coupling strength, but not in the mean phase
(Table2). When comparing the change in the peak power
of the oscillation and the change in the ﬁring rate of the
recorded cells, we found a linear relationship both in the
case of pyramidal cells (r =0.58, n=6, P =0.04; Fig.2B,
right panel) and of FSBCs (r =0.48, n=7, P =0.04,
Fig.2C, right panel). Thus, larger reductions in the peak
power of gamma oscillations caused by CB1Ra c t i v a t i o n
were accompanied by a more suppressed and less precise
ﬁring activity in CA3 neurons.
CB1R activation suppresses monosynaptically evoked
EPSCs in CA3 pyramidal cells and fast spiking basket
cells in the presence of carbachol
The microcircuits comprising pyramidal cells and FSBCs
generate the cholinergically induced gamma oscillation in
hippocampalslices,butatwhichsynapsesdocannabinoids
control the neurotransmission? A recent study elucidated
that synaptic communication between CA3 pyramidal
c e l l si sr e g u l a t e db yC B 1R activation (Hofmann et al.
2008), similar to that observed in other hippocampal
subﬁelds (Misner & Sullivan, 1999; Chiu & Castillo,
2008; Xu et al. 2010). To test whether excitatory synaptic
transmission between CA3 pyramidal cells would be
sensitive to cannabinoids under the conditions used
to induce oscillations in this study, we performed the
followingexperimentsinthepresenceof10μMcarbachol.
Excitatory postsynaptic currents (EPSCs) were evoked by
stimulation of ﬁbres in the stratum radiatum. In CA3
pyramidal cells, both CP55,940 and WIN55,212-2 (bath
applied at 1μM) signiﬁcantly reduced the peak amplitude
of the evoked currents (68.9±5.1% and 76.4±9.1%
of control, n=6 and 5, respectively; Table3; Fig.3A
and D). Next, we examined the sensitivity of EPSCs in
FSBCsmeasuredunderidenticalconditions.Similartothe
ﬁndings obtained in CA3 pyramidal cells, but in contrast
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to previous data (Hoffman et al. 2003), application of
both cannabinoid agonists (CP55,940 and WIN55,212-2
at a concentration of 1μM) substantially suppressed the
amplitude of evoked events in FSBCs (63.9±3.8% and
68.3±7.2%,n=9andn=5,respectively;Table3,Fig.3B
and D). After 20min of cannabinoid treatment, 1μlo f
10mM NBQX applied directly to the recording chamber
(volume of 1ml) readily eliminated all evoked currents
recorded in both cell types, conﬁrming that primarily
AMPA/kainate-mediated synaptic currents were evoked
(Fig.3AandB).Inaddition,thespeciﬁcityoftheeffectsof
cannabinoids was also tested in CB1R knockout animals.
No signiﬁcant effect was found in the case of CP55,940
application on evoked EPSCs in CA3 pyramidal cells
(97.4±8.9% of control n=6; Table3, Fig.3D)o ri n
FSBCs (93.6±4.3% of control n=4; Table3, Fig.3D),
verifying the selective activation of CB1Rs by CP55,940.
These observations suggest that excitatory synaptic trans-
mission received by both CA3 pyramidal cells and FSBCs
could be substantially reduced by cannabinoids in a
CB1R-dependent manner during cholinergic receptor
activation.
CB1R activation has no effect on monosynaptically
evoked IPSCs recorded in CA3 pyramidal cells in the
presence of carbachol
Next, we checked the cannabinoid sensitivity of synaptic
inhibitory transmission under the present recording
conditions. Pharmacologically isolated IPSCs evoked
by stimulation of ﬁbres in the stratum pyramidale
were recorded in CA3 pyramidal cells in the pre-
sence of carbachol (10μM). Bath application of CB1R
agonists (CP55,940 and WIN55,212-2 at 1μM)d i d
not produce any effect on the IPSC amplitude
(101.59±9.32% and 100.87±9.85% of control, n=5
and 4, respectively; Table3, Fig.3C and D). These data
are in line with earlier ﬁndings showing that perisomatic
inhibition, which is critical for gamma oscillations,
predominantly originates from cannabinoid-insensitive
GABAergic terminals (Fukudome et al. 2004; Neu et al.
2007; Szabo et al. 2010), since GABA release from
the axon endings of CB1R-expressing interneurons is
almost completely muted in the presence of carbachol
at a concentration higher than 5μM (Gulyas et al.
2010). Moreover, our results are also consistent with the
hypothesis that cannabinoids do not suppress gamma
oscillations through the direct reduction of phasic
inhibitory input onto CA3 pyramidal cells, but rather
act by decreasing the excitatory drive in the hippocampal
network.
Figure 2. Effect of CB1R activation on the ﬁring frequency of
CA3 pyramidal cells and fast spiking basket cells during
carbachol-induced gamma oscillations
A, simultaneous extracellular recordings of ﬁeld potentials in the
stratum pyramidale of CA3 (top black traces) during
carbachol-induced oscillations and spike trains recorded in a
loose-patch mode (bottom black traces) from a post hoc
anatomically identiﬁed CA3 pyramidal cell (left) and a fast spiking
basket cell (right). The CB1R agonist CP55,940 (1 μM) reduces the
ﬁring frequency of both cell types (lower grey traces) along with the
power of the oscillation (upper grey traces). CCh, carbachol. Scale
bars, 0.1 mV (ﬁeld potentials) or 0.2 mV (spike recordings) and
50 ms. B and C, left, summary of the effect of the CP55,940
application on the ﬁring rate of each measured CA3 pyramidal cell
(triangles) and FSBC (circles) showing a clear reduction in all cases.
The vertical bars adjacent to the pairwise comparisons indicate
medians and interquartile ranges of the corresponding data (ﬁlled
symbols). B and C, right, a linear relationship was found between
the change in the peak power of the oscillation and the change in
the ﬁring rate of the recorded cells, both normalized to control.
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Table 2. Firing properties of CA3 pyramidal cells and fast spiking basket
cells during carbachol-induced oscillations under control conditions and
20 min after drug application
CA3 pyramidal cells (n = 6)
Control CP55,940 P value
Firing frequency (Hz) 5.4 (1.7–7.2) 2.6 (0.6–4.5) 0.031
Spikes/oscillation cycle 0.19 (0.07–0.26) 0.08 (0.02–0.17) 0.031
Phase (deg) 7.7 ± 6.3 10 ± 7.8 0.62
Phase-coupling strength 0.69 (0.67–0.72) 0.58 (0.44–0.69) 0.031
CA3 fast spiking basket cells (n = 7)
Control CP55,940 P value
Firing frequency (Hz) 35.1 (25.7–85.1) 23.8 (12.1–64.6) 0.015
Spikes/oscillation cycle 1.07 (0.75–2.46) 0.74 (0.43–1.82) 0.015
Phase (deg) 23 ± 13.3 33.1 ± 22.6 0.358
Phase-coupling strength 0.83 (0.8–0.85) 0.78 (0.73–0.79) 0.015
Dataarepresentedasthemedianwithinterquartilerangeinparentheses,
except for phase values, which are given as the mean phase ± circular SD.
Signiﬁcant changes are indicated in italics.
Table 3. Effect of cannabinoid receptor agonists on the peak amplitude of electrically evoked
postsynaptic currents (PSC) recorded in CA3 neurons
Genotype Cell type PSC type Control (pA) CP55,940 (pA) P value Number
WT PC EPSC 114.8 ± 40.47 9 .2 ± 37.7 0.041 6
FSBC EPSC 343.9 ± 59.2 220.4 ± 42.8 0.0007 9
PC IPSC 141.1 ± 11.9 148.6 ± 21.10 . 2 9 5
CB1R KO PC EPSC 106.1 ± 57.19 8 .2 ± 53.80 . 1 6 6
FSBC EPSC 109.3 ± 21.7 101.3 ± 20.10 . 5 3 4
Genotype Cell type PSC type Control (pA) WIN55,212-2 (pA) P value Number
WT PC EPSC 110.5 ± 61.28 4 .5 ± 62.3 0.047 5
FSBC EPSC 242.5 ± 48.5 164 ± 39.9 0.025 5
PC IPSC 100.7 ± 61.5 101.5 ± 76.20 . 5 6 4
Data were compared using the Student’s paired t test: signiﬁcant differences are indicated in
italics. Data are presented as mean ± SEM. PC, pyramidal cell; FSBC, fast spiking basket cell.
The reduced spiking frequency of fast spiking basket
cells alone may account for a signiﬁcant drop in the
oscillation power upon CB1R activation
Finally, we attempted to differentiate the relative roles
of CA3 pyramidal cells and FSBCs in mediating the
cannabinoid effect on gamma oscillations. To address
this question, we took advantage of the distinct temporal
efﬁcacy of CP55,940 on the suppression of EPSC
amplitudes observed in the two cell types. As Fig.3A
and B indicated, this cannabinoid receptor ligand seemed
to reduce the EPSC amplitude recorded in FSBCs faster
than in pyramidal neurons. To quantify this difference,
we calculated the changes in the peak amplitude every
5min from the beginning of the drug superfusion. EPSC
amplitudesevokedinFSBCsshowedasigniﬁcantdecrease
at 5 and 10min (P <0.001) compared to control, but
no change in the EPSC amplitudes recorded in CA3
pyramidal cells could be observed (Fig.4A, Table4).
This signiﬁcant difference in the changes of the peak
amplitudes between the two cell types upon CP55,940
treatment could not be observed at the second half of the
2 0 m i np e r i o d( 1 5 m i n :P =0.52; 20min: P =0.48), as
the peak amplitude of EPSCs recorded in CA3 pyramidal
cells started to decrease gradually from 15min onwards
(Fig.4A). Examination of the effect of CP55,940 on the
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Figure 3. Cannabinoid agonists reduce the monosynaptically
evoked EPSCs (eEPSCs) recorded in CA3 pyramidal cells and
fast spiking basket cells, but have no effect on IPSCs measured
in CA3 pyramidal cells in the presence of carbachol
A and B, upper traces show typical mean EPSCs evoked in the
stratum radiatum of CA3 recorded in a CA3 pyramidal cell (A)o ri na
FSBC (B) in control (black) and after CP55,940 (1 μM,g r e y )
application. Plots (lower panels) of the peak amplitude of eEPSCs
show a reduction upon CP55,940 application (black lines indicate
the wash-in period of the drug). NBQX, an antagonist of
AMPA/kainate-type glutamate receptors, was applied in each case at
the end of the recording to verify that EPSCs were recorded. C,
typical mean IPSC (upper panel) recorded in a CA3 pyramidal cell
before (black trace) and after (grey trace) application of CP55,940
(1 μM). Lower panel shows the amplitude plot of eIPSCs. No change
in the peak amplitude can be detected after the application of the
CB1R agonist (black line). D, graph summarizing the effect of
CP55,940 (CP, open columns) and WIN55,212-2 (WIN, grey
columns) application on the evoked excitatory and inhibitory PSCs.
The normalized peak amplitudes after drug application compared to
control (dashed line) are shown. Hashed columns represent the
results obtained in CB1R knockout animals. Scale bars, 30 pA and
10 ms.
spiking activity of individual neurons as well as on the
oscillation power at the same time points showed that
at 5min pyramidal cell spiking was not signiﬁcantly
different from the control (90.8±2.5% of control, n=6,
P =0.09), whereas the ﬁring frequency of FSBCs was
already signiﬁcantly suppressed (73.9±6.7% of control,
n=7, P =0.01). The peak power of gamma oscillations
decreased in parallel with the FSBC ﬁring (Fig.4B and C;
Figure 4. The reduced spiking frequency of fast spiking basket
cells is already accompanied by a signiﬁcant drop in the
oscillation power, while pyramidal cell ﬁring is still unaltered
A, time course of the decrease of EPSC amplitudes recorded in CA3
pyramidal cells (PC) and in fast spiking basket cells (FSBC) during
CP55,940 wash-in. Note that in the ﬁrst 10 min no change in the
EPSC amplitude measured in pyramidal cells could be detected,
whereas EPSCs in fast spiking basket cells were already depressed
even after 5 min of drug application. Asterisks indicate the
signiﬁcant difference between the two cell types. B, superfusion of
CP55,940 caused a gradual decrease in spiking frequency of
pyramidal cells and fast spiking basket cells during ongoing gamma
oscillations. At 5 min, however, there was no substantial change in
the spiking frequency of pyramidal cells, but the discharge rate of
fast spiking basket cells was signiﬁcantly suppressed (asterisk). At
later time points no signiﬁcant difference in the magnitude of the
reduction in ﬁring rate could be noticed between the two cell types.
C, in the same experiments as in B, the oscillation power was
signiﬁcantly reduced already 5 min after drug application, a
reduction that further developed as CP55,940 was perfused. Circles
and triangles represent data obtained in two populations of slices,
where CA3 pyramidal cells and FSBCs, respectively, were measured.
Data are presented as mean ± SEM.
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Table 4. Change in the peak amplitude of electrically evoked EPSCs recorded in CA3
neurons at different time points from the beginning of CP55,940 application
% of control amplitude % of control amplitude
Time points in PC (n = 6) P value in FSBC (n = 9) P value
5 min 102.4 ± 2.10 . 2 7 8 7 .6 ± 2.7 0.031
10 min 100.9 ± 4.90 . 8 5 7 9 .3 ± 3.6 0.009
15 min 74.6 ± 5.9 0.03 70.7 ± 3.3 0.008
20 min 68.9 ± 5.1 0.041 63.9 ± 3.8 0.0007
Data were compared using the Student’s paired t test: signiﬁcant differences are
indicated in italics. Data are presented as mean ± SEM. PC, pyramidal cell; FSBC, fast
spiking basket cell.
peak power in slices where pyramidal cells were recorded:
75.9±3.4% of control, n=6, P =0.001; peak power
in slices where FSBCs were recorded: 69.1±7.9% of
control, n=7, P =0.047). At the 10, 15 and 20min
time points no signiﬁcant difference could be detected
in the changes of spiking activity and oscillation power
(Fig.4B and C, P >0.1). Figure4C demonstrates that
there was no signiﬁcant difference in the kinetics of the
power decrease between the two slice populations, where
the CA3 pyramidal cells and the FSBCs were measured.
Similarly, the peak power of the oscillations in control
conditions did not differ either (peak power in slices
where pyramidal cells were recorded: 146.5±16.7μV2,
n=6; peak power in slices where FSBCs were recorded:
117.3±25.6μV2, n=7, P =0.45). The coincidence of
the drop in oscillation power and the decrease in the
ﬁring activity of FSBCs, but not of pyramidal cells,
at the beginning of CP55,940 treatment suggests that
cannabinoideffectsongammaoscillationscouldprimarily
be mediated by the suppression of FSBC function,
producing less perisomatic inhibitory current and thus
smaller oscillations (Gulyas et al. 2010; Oren et al.
2010).However,uponlongercannabinoidapplicationthe
reduceddischargerateofpyramidalcells,causingevenless
excitatorydriveontoFSBCs,canalsocontributetothefull
reduction in the oscillation power.
Effect of CB1R activation on sharp wave-ripple
activities in the hippocampus
In addition to gamma oscillations, the CA3 region of
the hippocampus can intrinsically generate SWRs that
propagateto CA1 driven by synaptic excitation originated
from Schaffer collaterals (Buzs´ aki et al. 1992). A previous
in vivo study showed that SWRs in CA1 could be reduced
by cannabinoids, an effect that can be explained by the
depressed glutamate release from Schaffer collaterals in
CA1 upon CB1Rs activation (Misner & Sullivan, 1999;
Kawamura et al. 2006; Robbe et al. 2006). However,
it is not clear whether cannabinoids could suppress
SWRs in CA3 or if only their propagation to CA1 is
impaired by CB1R activation. Therefore, we tested the
cannabinoid sensitivity of SWRs in the CA3 region of the
hippocampal slices. A patch pipette ﬁlled with aCSF was
placedtothestratumpyramidaletomonitorthelocalﬁeld
potentials. After obtaining a control period, CP55,940 at
a concentration of 1μM was bath applied. We observed
that both the peak amplitude of SWRs (control:254.9μV,
125.2μV (median and interquartile range, respectively);
in CP55,940: 215.4μV, 116.1μV, n=8, P =0.007) and
their incidence (control: 0.69Hz, 0.36Hz (median and
interquartile range, respectively); in CP55,940: 0.38Hz,
0.46Hz, n=8, P =0.01, Wilcoxon Signed Rank test) was
signiﬁcantly reduced (Fig.5). These data propose that not
only gamma oscillations, but SWRs in the hippocampal
CA3networkscanbereadilysuppressedbycannabinoids.
Discussion
The main ﬁndings of the present study are as follows: (1)
Cholinergicallyinducedhippocampalgammaoscillations
can be dampened by exogenous cannabinoids in a
CB1R-dependent manner; (2) Decreased peak oscillatory
power upon CB1Ra c t i v a t i o ni sa c c o m p a n i e db yr e d u c e d
and less precise ﬁring activity in CA3 pyramidal cells and
FSBCs, neuron types that are critically involved in the
generation of ﬁeld oscillations in this model; (3) In the
presence of carbachol, CB1R activation can signiﬁcantly
suppressexcitatorysynaptictransmissionrecordedinCA3
pyramidal cells and FSBCs, whereas pyramidal cell peri-
somatic inhibitory currents are unaffected; (4) At the
beginning of CP55,940 superfusion in slices, a signiﬁcant
drop in oscillation power coincides with the reduced
ﬁring of FSBCs, while pyramidal cell spiking is still
unchanged; (5) Cannabinoids can also suppress SWRs in
the CA3 region of hippocampal slices. Since CB1Rs are
predominantly,ifnotexclusively,locatedataxonterminals
in the hippocampus, our data propose that the decrease
in excitatory synaptic input upon activation of these
receptors can result in fewer action potential discharges
withlowerﬁdelityduringsynchronousnetworkactivities,
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which may account for the impairment of hippocampal
oscillations observed after cannabinoid treatment.
Our results clearly show that the excitatory input not
only onto CA3 pyramidal cells but also onto FSBCs could
bereducedbycannabinoidsactivatingCB1Rs.Thisﬁnding
seems to be in contrast to that published previously
(Hoffman et al. 2003), where evoked EPSCs recorded
in CA1 interneurons located outside of the pyramidal
cell layer were found to be insensitive to cannabinoid
ligands. Since FSBCs can be predominantly found within
thestratumpyramidale(Katsumaruetal.1988),itislikely
that this GABAergic cell type was not among the inter-
neurons tested by Hoffman et al. (2003). Alternatively, we
cannot rule out the possibility that recurrent collaterals
in CA3 targeting local interneurons express CB1Rs, but
that Schaffer collaterals in CA1 synapsing on GABAergic
cells do not. Further studies might clarify the apparent
contradiction between these observations.
In a previous report, we found that the μ-opioid
receptor agonist DAMGO could effectively diminish
cholinergically induced network oscillations in
hippocampal slices (Gulyas et al. 2010). Although
both DAMGO and cannabinoids reduced the oscillation
power, the cellular mechanisms underlying their
effects were quite different. The activation of μ-opioid
receptors located speciﬁcally at axon terminals of
parvalbumin-containing interneurons suppressed GABA
release (Drake & Milner, 2002; Glickfeld et al. 2008;
Gulyas et al. 2010) and led to de-synchronization of
neuronalﬁringwithoutchangingthemeandischargerate.
Similarly, it was recently proposed that the agonists of H3
histamine receptors could dampen gamma oscillations
predominantly via the de-synchronization of ﬁring of
CA3 pyramidal cells with no effects on their spiking
activity (Andersson et al. 2010). In contrast, we ﬁnd here
that the cannabinoid-induced decrease in the excitatory
synaptic transmission predominantly onto FSBCs can
already cause a signiﬁcant reduction in their mean
ﬁring frequency (Fig.4). As a result, the magnitude of
synchronous GABA release from FSBC axon terminals
generating the ﬁeld oscillation in CA3 is substantially
depressed, producing smaller ﬂuctuations in the ﬁeld
potentials (Oren et al. 2010). However, the reduced
dischargerateofpyramidalcells(Figs2and4),producing
even smaller excitatory drive onto FSBCs, may contribute
to the full suppression of the oscillation power upon
cannabinoid treatment. These results are consistent with
the notion that the reduction of ﬁeld oscillations, e.g. by
anaesthetics, may indicate the suppression of synaptic
transmission (Destexhe et al. 2003).
Excitatory synaptic transmission is critical for
carbachol-induced oscillations, since blocking AMPA
receptors diminishes rhythmic activities (Fisahn et al.
1998; Mann et al. 2005). Furthermore, application of
a selective AMPA receptor antagonist resulted in the
hyperpolarization of the resting membrane potential of
CA3 pyramidal cells, and abolished the rhythmic ﬁring
of FSBCs (Mann et al. 2005), which has been shown
to be driven by phasic excitatory input (Traub et al.
2000; Oren et al. 2006). The tonic depolarizing effect of
AMPA receptor activation probably promotes pyramidal
cell discharge, which is consistent with results indicating
that slow, non-rhythmic excitatory input onto pyramidal
cellsduringgammaoscillationsmaybeenoughtosupport
the spiking of principal neurons synchronized by peri-
somatic inhibition (Fisahn et al. 1998; Traub et al. 2000;
Mann et al. 2005; Morita et al. 2008). These observations
together suggest that a partial reduction in excitatory
synaptic transmission, e.g. after cannabinoid treatment
(Fig.3), can reduce the excitability of CA3 pyramidal cells
inarecurrentnetwork.Thepredictionthatthiswillreduce
the number of neurons ﬁring synchronously during a
gammacycleissupportedbyourrecordings(Fig.2)andby
modelling studies (Traub et al. 2000; Morita et al. 2008).
The resulting smaller neuronal assembly will produce a
lower excitatory drive onto FSBCs. This reduced phasic
excitation from a smaller neuronal population together
Figure 5. CB1R activation by CP55,940 signiﬁcantly suppresses
sharp wave-ripple activities in the CA3 region of hippocampal
slices
A, 10-s-long ﬁeld recordings before and after drug application
indicate marked decrease in the peak amplitude of spontaneously
occurring population events. Dashed lines show the detection
threshold. B, example events are enlarged. Scale bars, 0.1 mV and
25 ms. C, the mean values of individual experiments (open circles)
and the corresponding medians and the interquartile ranges (ﬁlled
circles) obtained in two conditions are shown.
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with the direct reduction of glutamate release onto FSBCs
upon CB1R activation is likely to be responsible for
the full cannabinoid effect on gamma oscillations. Our
observation that the signiﬁcant suppression of the FSBC
discharge rate was already accompanied by a drop in the
oscillation power, while the pyramidal cell spiking was
still unaltered, is in full agreement with a recent study
proposing that the reduction of excitatory input solely
ontoFSBCsmightbesufﬁcienttosuppressinvitrogamma
oscillations (Fuchs et al. 2007).
In vivo studies uncovered that cannabinoids could
effectivelydepressoscillatoryactivitiesinseveralfrequency
bands in the CA1 region of the hippocampus (Robbe
et al. 2006; Hajos et al. 2008). At low doses, CP55,940
caused only de-synchronization of the ﬁring of CA1
neurons without a signiﬁcant change in their frequency,
aneffectthatwasalreadyaccomplishedbythedampening
of the rhythmic activities detected in local ﬁeld
potentials. At high doses, however, the ﬁring rate was
signiﬁcantly suppressed (Robbe et al. 2006). During
exploratory behaviour, when the theta rhythm dominates
hippocampal ﬁeld potentials, input from the entorhinal
cortex might prevalently inﬂuence the ﬁring of CA1
neurons (Buzs´ aki, 1989; Brun et al. 2002). In contrast,
their spiking during SWRs, which characterize local ﬁeld
potentials in CA1 during consummatory behaviour and
slow wave sleep, is mainly controlled by excitation from
CA3 (Buzs´ aki, 1989; Buzs´ aki et al. 1992; Nakashiba et al.
2009). Importantly, a recent in vitro study revealed that
excitatory synaptic input from the entorhinal cortex
onto CA1 pyramidal cells could be depressed only to
a small extent upon CB1R activation, in contrast to
excitatory synaptic transmission originating from CA3,
which was signiﬁcantly reduced (Xu et al. 2010). Taking
into account these results, we hypothesize that CP55,940
at low doses may not signiﬁcantly attenuate the excitatory
drive onto CA1 neurons from entorhinal cortex during
theta rhythms, and thus the frequency of spiking would
not be substantially changed, whereas the impairment in
the temporal structure of the ﬁring may be explained
by the reduced excitation from CA3 (Jarsky et al. 2005;
Katz et al. 2007). This proposal is supported by in vivo
ﬁndings,showingthatSWRsinCA1thataregeneratedby
the synchronous population discharge of CA3 pyramidal
cells via Schaffer collaterals (Buzs´ aki et al. 1992) are
signiﬁcantly suppressed after CP55,940 treatment (Fig.5)
(Robbeetal.2006).Theseobservationsareinlinewithour
present results indicating that the reduction in synaptic
excitation of CA3 pyramidal cells may underlie the
cellular mechanisms of the CB1R-dependent dampening
of synchronous activities in hippocampal networks.
Thus, cannabinoids could mainly alter intrahippocampal
excitatorysynaptictransmission,leadingtoimpairmentof
oscillatoryactivitiesandmemoryformation(Hampson&
Deadwyler, 1998; Robbe & Buzsaki, 2009).
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